ADM
Catalysts
Key Risks
The Opportunity
Archer Daniels Midland is one of the four companies that basically control the global food supply chain - they buy crops from farmers, process them into ingredients like cooking oils, animal feed, sweeteners, and biofuels, and ship them around the world. Think of them as the giant invisible middleman between a soybean field in Iowa and a bottle of vegetable oil on your kitchen shelf.
The stock has had a wild ride. A few years ago, during the post-pandemic commodity boom, ADM was printing money - earning nearly $8 per share in 2022. Then crop prices crashed back to earth, and earnings fell off a cliff to just $2.23 per share in 2025. To make things worse, regulators caught the company inflating the profits of its nutrition business through accounting tricks, resulting in a $40 million SEC fine and the departure of key executives. The stock got hammered, bottoming near $52 in early 2026.
Now the recovery story is kicking in. The company just posted a blowout quarter with earnings nearly doubling expectations, raised its full-year forecast significantly, and is benefiting from favorable government biofuel policies worth around $250 million. They also hired a new chief operating officer from one of the world's largest agricultural companies, signaling a fresh start operationally. The stock has responded by rallying 53% over the past year.
The problem is that the rally may have gotten ahead of the fundamentals. At $80, the stock is already pricing in most of the good news. Earnings are recovering but remain well below the 2022 peak, and commodity processing is inherently a low-margin, cyclical business. The most relevant valuation methods suggest fair value in the $60-$78 range, meaning the stock is trading near the top of its reasonable value band. The main risk is that the current crush margins and biofuel tailwinds prove temporary, and earnings settle back into the $4-$5 range - at which point a $75-$80 stock price would look expensive. The main thing that could go right is if the restructuring program delivers its promised savings and the nutrition business sustains its recovery, justifying a higher sustained earnings base.
Breakdown
ADM reports total assets of $53.53B against total liabilities of $29.66B as of Q2 2026, yielding book equity of $23.58B or $48.93 per share vs. the current price of $80.30 (P/B 1.64x). The balance sheet is dominated by working capital tied to commodity inventories and receivables - these are generally realizable near book given the liquid nature of grains and oilseeds. However, the Nutrition segment carries meaningful goodwill and intangibles from past acquisitions, and the SEC accounting fraud settlement [SEC Press Release, January 2026] revealed that Nutrition's operating profit was artificially inflated through retroactive intersegment adjustments in FY2021-2022, casting doubt on the economic value originally assigned to those acquired assets.
Total debt (current $1.56B + long-term $6.45B = $8.01B) against equity of $23.58B yields a D/E of 0.34x - conservative for the sector. Cash of $1.06B is modest relative to $8B in debt, but the commodity trading business generates substantial operating cash flow seasonally. ADM's equity in affiliates, particularly its ~25% stake in Wilmar International, represents a significant off-balance-sheet asset whose fair value likely exceeds book.
The Alltech-ADM animal feed JV (closed Q1 2026) [AgTech Navigator, September 2025] also shifted asset composition, exchanging 11 complete feed mills for a minority stake in a larger entity. Net asset value provides a floor around $49/share, but the real question is earning power on those assets - ROE at 7.5% is below cost of equity for most reasonable WACC assumptions, suggesting the assets are not generating adequate returns at present.
ADM's free cash flow was $1.68B on a trailing twelve-month basis, yielding $3.48/share in FCF against a dividend of approximately $2.08/share (2.6% yield). On FY2025 reported EPS of $2.23, the payout ratio reached a precarious 91.6% - far too high for a cyclical commodity processor. However, this reflects the earnings trough; on the raised FY2026 guidance midpoint of $5.37, the payout ratio normalizes to approximately 39%, which is well-covered.
ADM has maintained 53 consecutive years of dividend increases [The Top 2 Consumer Staples Stocks to Buy Right Now, March 2026], making it a Dividend Aristocrat, but the commitment to growing the dividend through deep earnings troughs puts balance sheet flexibility at risk. Capital allocation has shifted toward restructuring: the company identified approximately $2B in portfolio streamlining opportunities and is targeting $500M-$750M in aggregate savings through 2025-2029, including eliminating up to 700 jobs [Food Dive, 2025]. The $103M Decatur facility modernization [Simply Wall St, 2026] represents disciplined brownfield investment at roughly one-quarter the capital intensity of greenfield builds.
Buyback activity has reduced shares from approximately 540M (2022) to 482M outstanding, a meaningful ~11% reduction. However, net insider transactions of -4 and institutional net selling of -1.45% signal modest caution from informed holders.
ADM's financial history reveals a classic commodity cycle. Revenue peaked at $101.6B in 2022 before declining to $80.3B in 2025, a 21% drop reflecting normalized crop prices post the 2021-2022 commodity supercycle. More concerning is the earnings trajectory: net income fell from $4.37B (2022) to $1.07B (2025), a 76% decline, and EPS dropped from $7.71 to $2.23 over the same period.
Gross margins have been thin and volatile, ranging from 6.3% (2025) to 8.0% (2023), typical for commodity processing but offering little buffer. Operating margins compressed from 4.1% (2022) to 1.2% (2025). The accounting fraud in the Nutrition segment [Investigate Midwest, January 2026] is a material governance failure - the SEC found that former executives directed retroactive intersegment adjustments to meet 15-20% annual operating profit growth targets, which means the reported 2021-2022 Nutrition profits were not reliable.
However, the Q2 2026 results show a meaningful inflection: revenue of $22.68B, operating income of $896M, and EPS of $1.87 represent a sharp rebound. Ag Services & Oilseeds segment profit surged 129% YoY, and Nutrition segment profit rose 51% YoY [GuruFocus Q2 2026 Earnings, August 2026]. Management has consistently beaten quarterly EPS estimates for the past five quarters, rebuilding some credibility after the scandal.
Management raised FY2026 adjusted EPS guidance to $5.15-$5.60 from $4.15-$4.70, a roughly 24% increase at the midpoint, driven by strong crush margins and Nutrition recovery [GuruFocus Q2 2026 Earnings, August 2026]. The 45Z biofuels tax credit benefit was also raised to approximately $250M for 2026, up from $150M, following regulatory clarity on RVOs and domestic feedstock incentives [GuruFocus Q2 2026 Earnings, August 2026]. Analyst consensus projects 15.4% EPS growth over the next 5 years, which I view as aggressive for a commodity processor whose 10-year average EPS is approximately $3.77. A more realistic sustainable EPS range is $4.50-$5.50, reflecting normalized crush margins and the partial benefit of restructuring savings.
The forward P/E of 14.9x on approximately $5.37 earnings appears reasonable against the peer median of 18.4x, but ADM's sub-7% net margins and cyclical earnings profile warrant a discount. The PEG ratio of 0.97 looks attractive if the 15.4% growth rate materializes, but I assign only medium confidence to that growth estimate given the commodity cycle exposure. The reverse DCF implies an 8.5% growth rate baked into the current price, which is more achievable but still assumes crush margins remain above mid-cycle levels.
Key assumption: the Q2 2026 earnings run rate is not fully sustainable, and normalization toward $4.50-$5.00 EPS in FY2027-2028 is probable as crush margins mean-revert.
ADM operates within the ABCD oligopoly (ADM, Bunge, Cargill, Louis Dreyfus) that collectively controls approximately 90% of global grain and oilseed trade [The Pig Site, July 2025]. This structure represents a significant barrier to entry - the capital requirements for global grain origination, storage, transportation, and processing infrastructure are enormous, and no material new entrants have emerged. ADM's moat rests on three pillars: (1) efficient scale in commodity processing, where decades of invested capital in elevators, ports, crushing plants, and rail/barge networks create a cost advantage that is nearly impossible to replicate; (2) switching costs in the Nutrition/specialty ingredients business, where customer formulations are developed around ADM's specific ingredient profiles; and (3) intangible assets in the form of long-standing farmer and buyer relationships globally.
However, the moat is narrowing modestly. Bunge's $8.2B merger with Viterra created a combined entity with 300+ facilities in 40+ countries and 56 crushing plants, explicitly positioning it to rival ADM and Cargill [World Grain, July 2025]. Additionally, the commodity processing core remains a low-margin, capital-intensive business where the moat protects market position but does not generate excess returns - ROE of 7.5% is below cost of equity.
The Nutrition business, which was intended to be the higher-margin growth engine, has been tarnished by the accounting scandal and is undergoing restructuring.
CEO Juan Luciano has led ADM since January 2015 and serves as Chairman, providing continuity but also raising concentration risk [Fintool profile]. His tenure spans ADM's strategic pivot toward nutrition and specialty ingredients, which delivered strong results in 2020-2022 but was undermined by the accounting fraud revelation. The SEC's $40M civil penalty for materially inflating Nutrition segment performance [SEC Press Release, January 2026] represents a serious governance failure, even though the DOJ dropped its criminal probe [DTN Progressive Farmer, January 2026].
The appointment of Carrie Nichol as Chief Accounting Officer (from Cargill, effective March 2025) [TipRanks, 2025] and the creation of a new COO role filled by Jeffrey Rowe (former Syngenta CEO, effective August 2026) [GuruFocus, August 2026] suggest the board is taking remedial action. Insider ownership at 0.68% is quite low for a company of this size - management's economic alignment with shareholders is primarily through compensation rather than ownership. The recent insider transactions are all director stock awards with zero open-market purchases, which provides no signal of conviction.
Capital allocation has been mixed: the buyback program has been effective (shares reduced ~11% since 2022), but the dividend was maintained through an earnings trough at a 91.6% payout ratio, prioritizing the Aristocrat streak over financial prudence.
Legal risk remains a tail factor. The $40M SEC settlement is booked, but the shareholder class action filed by Glancy Prongay Murray LLP [BusinessWire, February 2024] is still pending and could generate incremental liability. Former CFO Vikram Luthar is fighting the SEC's charges in federal court [CFO Dive], creating ongoing headline risk.
Competitive risk is elevated with the Bunge-Viterra merger intensifying rivalry in ADM's core markets [World Grain, July 2025]. Commodity price risk is inherent - the 2022-2025 earnings decline from $7.71 to $2.23 EPS demonstrates the cyclicality. Biofuels policy risk cuts both ways: the 45Z credit provides $250M in tailwind for 2026, but political changes could reduce or eliminate this benefit.
Geopolitical risks remain relevant given ADM's global grain merchandising exposure. The 91.6% payout ratio during the trough, while normalizing, indicates limited margin of safety on the dividend if earnings disappoint again. Short interest at 3.68% with a 4.73-day cover ratio suggests modest bearish positioning but nothing extreme.
The beta of 0.61 indicates lower-than-market volatility, consistent with a defensive staples business.
The global fats and oils market is valued at approximately $484B and projected to reach $698B by 2034, a CAGR of ~4.2% [Verified Market Research, 2025]. Specialty fats and oils are growing faster at 7.6-10% CAGR [The Business Research Company, 2026]. ADM is well-positioned in this growing market as one of the four dominant processors globally.
Institutional ownership is high at 87.6%, anchored by passive giants Vanguard (~14%), BlackRock (~8-9%), and State Street (~7%) [Simply Wall St, 2026; Fintel.io, 2026]. No activist positions were identified. The analyst consensus recommendation of 3.27 (between hold and underperform) with a target price of $77.11 - below the current price of $80.30 - suggests the recent rally has outrun sell-side expectations.
ADM is actively reshaping its portfolio, exploring a sale of Golden Peanut and Tree Nuts [Food Dive, 2025] and completing the Alltech animal feed JV [AgTech Navigator, September 2025]. No inbound takeover interest was identified. The protein ingredients market ($83B growing to $122B by 2031, 7.9% CAGR) [Protein Ingredients Market report, June 2026] and feed additives market ($51B to $68B by 2031, 6% CAGR) [Feed Additives Market report, March 2026] provide secular growth runways for ADM's value-added businesses.